SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Jan-24 4:42 PM View: | Coherus Biosciences, Inc. (CHRS) | 31-Dec-23 | Payment of Exercise | 18,440 | $3.33 | $61,405.20 | (20%) 93.75K to 75.31K | |
04-Apr-23 8:56 PM View: | Coherus Biosciences, Inc. (CHRS) | 01-Apr-23 | Payment of Exercise | 3,457 | $6.84 | $23,645.90 | (3%) 105.71K to 102.25K | |
24-Jan-23 4:45 PM View: | Coherus Biosciences, Inc. (CHRS) | 20-Jan-23 | Grant | 40,000 | -- | -- | 62% 64.24K to 104.24K | |
06-Jan-23 6:14 PM View: | Coherus Biosciences, Inc. (CHRS) | 04-Jan-23 | Payment of Exercise | 5,437 | $9.87 | $53,663.20 | (8%) 69.68K to 64.24K | |
05-Apr-22 5:19 PM View: | Coherus Biosciences, Inc. (CHRS) | 01-Apr-22 | Payment of Exercise | 3,458 | $12.85 | $44,435.30 | (5%) 73.14K to 69.68K | (11%) |
06-Jan-22 7:50 PM View: | Coherus Biosciences, Inc. (CHRS) | 04-Jan-22 | Grant | 40,000 | -- | -- | 121% 33.14K to 73.14K | |
19-Oct-21 7:36 PM View: | Coherus Biosciences, Inc. (CHRS) | 15-Oct-21 | Market Sale | 3,507 | $16.80 | $58,918.70 | (10%) 35.12K to 31.61K | (2%) |
10-Jun-21 4:35 PM View: | Coherus Biosciences, Inc. (CHRS) | 09-Jun-21 | Market Purchase | 3,700 | $13.42 | $49,667.70 | 12% 31.42K to 35.12K | < 1% |
30-Apr-21 4:38 PM View: | Coherus Biosciences, Inc. (CHRS) | 28-Apr-21 | Grant | 20,000 | -- | -- | 200% 10.0K to 30.0K |